Royal Bank of Canada’s Vaxart VXRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-223,866
| Closed | -$101K | – | 7567 |
|
|
2025
Q2 | $101K | Buy |
223,866
+223,260
| +36,842% | +$97.1K | ﹤0.01% | 5607 |
|
|
2025
Q1 | $0 | Buy |
606
+326
| +116% | +$209 | ﹤0.01% | 7268 |
|
|
2024
Q4 | $0 | Hold |
280
| – | – | ﹤0.01% | 7289 |
|
|
2024
Q3 | $0 | Sell |
280
-188
| -40% | -$144 | ﹤0.01% | 7509 |
|
|
2024
Q2 | $0 | Buy |
468
+27
| +6% | +$22 | ﹤0.01% | 7586 |
|
|
2024
Q1 | $1K | Sell |
441
-4,884
| -92% | -$5.12K | ﹤0.01% | 6879 |
|
|
2023
Q4 | $3K | Buy |
5,325
+2,045
| +62% | +$1.41K | ﹤0.01% | 6755 |
|
|
2023
Q3 | $2K | Sell |
3,280
-4,950
| -60% | -$3.77K | ﹤0.01% | 6823 |
|
|
2023
Q2 | $6K | Sell |
8,230
-2,443
| -23% | -$2.27K | ﹤0.01% | 6636 |
|
|
2023
Q1 | $8K | Sell |
10,673
-11,742
| -52% | -$10.9K | ﹤0.01% | 6426 |
|
|
2022
Q4 | $22K | Buy |
22,415
+12,909
| +136% | +$18.2K | ﹤0.01% | 6268 |
|
|
2022
Q3 | $20K | Sell |
9,506
-1,392
| -13% | -$4.8K | ﹤0.01% | 6150 |
|
|
2022
Q2 | $38K | Sell |
10,898
-6,821
| -38% | -$25.5K | ﹤0.01% | 5843 |
|
|
2022
Q1 | $89K | Sell |
17,719
-19,902
| -53% | -$101K | ﹤0.01% | 5738 |
|
|
2021
Q4 | $236K | Buy |
37,621
+15,918
| +73% | +$109K | ﹤0.01% | 5177 |
|
|
2021
Q3 | $173K | Sell |
21,703
-1,677
| -7% | -$13.8K | ﹤0.01% | 5304 |
|
|
2021
Q2 | $175K | Buy |
23,380
+8,578
| +58% | +$59.9K | ﹤0.01% | 5192 |
|
|
2021
Q1 | $90K | Buy |
14,802
+871
| +6% | +$6.7K | ﹤0.01% | 5534 |
|
|
2020
Q4 | $79K | Buy |
13,931
+12,596
| +944% | +$80.1K | ﹤0.01% | 5458 |
|
|
2020
Q3 | $9K | Buy |
1,335
+235
| +21% | +$2.09K | ﹤0.01% | 5968 |
|
|
2020
Q2 | $10K | Buy |
+1,100
| New | +$3.16K | ﹤0.01% | 5840 |
|
|
2019
Q2 | – | Sell |
-9
| Closed | – | – | 7217 |
|
|
2019
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 7134 |
|
|
2018
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 7150 |
|
|
2018
Q3 | $0 | Buy |
+9
| New | +$27 | ﹤0.01% | 6969 |
|
|
2018
Q2 | – | Sell |
-3
| Closed | – | – | 6794 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 6830 |
|
|
2017
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 6926 |
|
|
2017
Q3 | $0 | Buy |
+3
| New | +$20 | ﹤0.01% | 7014 |
|
|
2017
Q2 | – | Sell |
-2
| Closed | – | – | 6789 |
|
|
2017
Q1 | $0 | Buy |
+2
| New | +$20 | ﹤0.01% | 6844 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 6279 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5852 |
|
Other funds holding VXRT
XT
HSA
BCMLT
CFO
LCM
HWA
Royal Bank of Canada's VXRT Position: Q3 2025 in Review
Royal Bank of Canada sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 223,866 shares — an estimated $101K sold.
Royal Bank of Canada first reported a position in VXRT in Q1 2017 and held it in 28 quarters. The position peaked at $236K in Q4 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.
- Royal Bank of Canada reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
- Royal Bank of Canada sold 223,866 Vaxart shares in Q3 2025, an estimated $101K.
- Royal Bank of Canada first reported a position in Vaxart in Q1 2017 and held it in 28 quarters.
- Royal Bank of Canada's Vaxart position peaked at $236K in Q4 2021.
- 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.
Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.